BURLINGAME, Calif.--(BUSINESS WIRE)--With current genetic tests for breast and ovarian cancer risk costing up to $4,000 or more, Color Genomics today announced the immediate availability of the Color ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Color Genomics today announced the Benefits Program for Genetic Testing for Breast and Ovarian Cancer Risk, a first-of-its-kind initiative to offer such testing to ...
Burlingame genetic testing company Color Genomics is adding a new test for hereditary high cholesterol — the firm’s first foray beyond the hereditary cancer field. Until now, Color, which launched in ...
An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback